Chartwell Investment Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Chartwell Investment Partners's NVS Position: Q1 2020 in Review
Chartwell Investment Partners sold out of Novartis (NVS) in Q1 2020, closing a stake of 23,439 shares — an estimated $2.22M sold.
Chartwell Investment Partners first reported a position in NVS in Q2 2013 and held it in 17 quarters. The position peaked at $3.3M in Q2 2019. 1,132 funds tracked by Wall St. Rank hold NVS as of Q1 2020.
- Chartwell Investment Partners reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
- Chartwell Investment Partners sold 23,439 Novartis shares in Q1 2020, an estimated $2.22M.
- Chartwell Investment Partners first reported a position in Novartis in Q2 2013 and held it in 17 quarters.
- Chartwell Investment Partners's Novartis position peaked at $3.3M in Q2 2019.
- 1,132 funds tracked by Wall St. Rank held Novartis as of Q1 2020.
Based on Chartwell Investment Partners's 13F filing for Q1 2020, filed 30 Apr 2020.